131 related articles for article (PubMed ID: 20963425)
1. Apoptotic protein expression in favorable-histology Wilms tumor correlates with tumor recurrence.
Agarwal S; Iyer VK; Agarwala S; Mathur SR; Aron M; Datta Gupta S; Verma K
Pediatr Surg Int; 2011 Mar; 27(3):303-8. PubMed ID: 20963425
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases.
Re GG; Hazen-Martin DJ; El Bahtimi R; Brownlee NA; Willingham MC; Garvin AJ
Int J Cancer; 1999 Apr; 84(2):192-200. PubMed ID: 10096254
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
Salama A; Kamel A
J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biologic significance of nuclear unrest in Wilms tumor.
Hill DA; Shear TD; Liu T; Billups CA; Singh PK; Dome JS
Cancer; 2003 May; 97(9):2318-26. PubMed ID: 12712489
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ
Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
[TBL] [Abstract][Full Text] [Related]
7. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
9. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
[TBL] [Abstract][Full Text] [Related]
10. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
[TBL] [Abstract][Full Text] [Related]
11. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
12. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
[TBL] [Abstract][Full Text] [Related]
13. The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based treatment.
Skírnisdóttir I; Seidal T
Oncol Rep; 2012 Mar; 27(3):741-7. PubMed ID: 22159712
[TBL] [Abstract][Full Text] [Related]
14. Glypican-3 mRNA expression level in Wilms tumor: correlation with histological type, stage, and outcome.
Wari MN; Vallonthaiel AG; Ahmed A; Saxena D; Iyer VK; Mathur SR; Agarwala S; Bakhshi S; Srinivas V; Chattopadhyaya P; Sharma A; Gupta SD; Dinda A
Pediatr Surg Int; 2017 Jun; 33(6):695-703. PubMed ID: 28432433
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor.
Teixeira RA; Odone-Filho V; de Camargo B; Zerbini MC; Fillipi R; Alencar A; Cristofani L
Pediatr Hematol Oncol; 2011 Apr; 28(3):194-202. PubMed ID: 21214406
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer.
Tannapfel A; Nüsslein S; Fietkau R; Katalinic A; Köckerling F; Wittekind C
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):585-91. PubMed ID: 9635706
[TBL] [Abstract][Full Text] [Related]
19. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.
Routh JC; Ashley RA; Sebo TJ; Lohse CM; Husmann DA; Kramer SA; Kwon ED
J Urol; 2008 May; 179(5):1954-9; discussion 1959-60. PubMed ID: 18355839
[TBL] [Abstract][Full Text] [Related]
20. Bim(L) displacing Bcl-x(L) promotes Bax translocation during TNFalpha-induced apoptosis.
Zhang L; Xing D; Chen M
Apoptosis; 2008 Jul; 13(7):950-8. PubMed ID: 18500555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
